Atossa Therapeutics to Participate at the Investor Summit Conference and Present to Investors on May 18, 2021

NEXT STORY
Atossa Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update
PREV STORY
Atreca to Present at Upcoming Virtual Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Heat Biologics Provides Second Quarter 2021 Business Update

author_avatar
NASDAQ Market News

Catalyst Pharmaceuticals Expands Leadership Team with Appointment of Preethi Sundaram, Ph.D. as Chief Product Development Officer

author_avatar
NASDAQ Market News

Innovation Pharmaceuticals Announces Publication of Peer-Reviewed Scientific Article in the Journal Viruses on the Anti-SARS-CoV-2 Properties of Brilacidin

author_avatar
NASDAQ Market News